AtriCure (NASDAQ:ATRC) Stock Price Down 5.5% After Insider Selling theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective cut by analysts at Canaccord Genuity Group from $57.00 to $49.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the medical device company’s stock. Canaccord Genuity Group’s target price indicates a potential upside of 120.52% from […]
AtriCure (NASDAQ:ATRC) Raised to Outperform at Oppenheimer theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Oppenheimer upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a market perform rating to an outperform rating in a research note published on Tuesday morning, Marketbeat.com reports. Oppenheimer currently has $32.00 price objective on the medical device company’s stock. A number of other research analysts also recently commented on ATRC. Stifel Nicolaus lowered their […]
Oppenheimer upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a market perform rating to an outperform rating in a research note published on Tuesday, MarketBeat Ratings reports. They currently have $32.00 price objective on the medical device company’s stock. Several other brokerages have also issued reports on ATRC. Stifel Nicolaus lowered their price target […]